Improving Epilepsy Programs, Services, and Outcomes through National Partnerships

$26.4 Million committed in FY2018–FY2023

Agency: Centers for Disease Control and Prevention, Health and Human Services, Department of
Assistance: Cooperative Agreements
CFDA number: 93.850
What it does: The purpose of this program is to: â€¢ Reduce the treatment gap (i.e., shortening the time to diagnosis, and increasing referral to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management); â€¢ Increase access to appropriate health care services, community resources, and self-management supports among people with epilepsy and their families; â€¢ Improve the publicâ€™s knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and â€¢ Improve health, social participation, and quality of life for people with epilepsy.
Who benefits: Individual/Family Racial/ethnic minority groups People with disabilities Specialty group Children Adults Older adults Schools Health Professional Educational Professional Student/trainee Low income Moderate income Rural Urban Suburban Education (0-13+) Nonprofit groups
Who applies: Reference posted NOFOs available on Grants.gov
Authorized by: This program is authorized under the sections 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. 241(a) and 247b(k)(2), as amended]
Program site: http://www.cdc.gov ↗

Committed by fiscal year

By dollars committed.

Committed through this program: Money committed under this assistance listing (its CFDA program), counted in the year each action happened.
How it's paid: Most programs pay out one way — a grant, or a direct payment to individuals; the flow bar only appears when a program genuinely mixes types.
Some recipients aren't itemized: For entitlement programs like Social Security and Medicare, the government reports one aggregate instead of naming tens of millions of people, so the recipient roster isn't part of the public record.
Awards, counted once: An award count is the number of distinct awards with at least one action that year — each counted once, however many times it was amended.
The colored bars: Every bar on this page splits by how the money moves:
Direct payments

Improving Epilepsy Programs, Services, and Outcomes through National Partnerships

$26.4 Million committed in FY2018–FY2023

Agency: Centers for Disease Control and Prevention, Health and Human Services, Department of
Assistance: Cooperative Agreements
CFDA number: 93.850
What it does: The purpose of this program is to: â€¢ Reduce the treatment gap (i.e., shortening the time to diagnosis, and increasing referral to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management); â€¢ Increase access to appropriate health care services, community resources, and self-management supports among people with epilepsy and their families; â€¢ Improve the publicâ€™s knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and â€¢ Improve health, social participation, and quality of life for people with epilepsy.
Who benefits: Individual/Family Racial/ethnic minority groups People with disabilities Specialty group Children Adults Older adults Schools Health Professional Educational Professional Student/trainee Low income Moderate income Rural Urban Suburban Education (0-13+) Nonprofit groups
Who applies: Reference posted NOFOs available on Grants.gov
Authorized by: This program is authorized under the sections 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. 241(a) and 247b(k)(2), as amended]
Program site: http://www.cdc.gov ↗